Covered recipient · General Payments record
RACHEL FARRAR
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,452.79
- Reported across 78 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $670.59 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $231.85 | 2 |
| Axsome Therapeutics, Inc. | $125.00 | 1 |
| REVANCE THERAPEUTICS, INC. | $118.71 | 1 |
| Amgen Inc. | $105.62 | 1 |
| ABBVIE INC. | $89.41 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.75 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107091446 | CMS |
| ABBVIE INC. | $21.43 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107091448 | CMS |
| ABBVIE INC. | $18.36 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107091450 | CMS |
| ABBVIE INC. | $24.87 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107091452 | CMS |
| Amgen Inc. | $105.62 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117249163 | CMS |
| AstraZeneca Pharmaceuticals LP | $106.85 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105253010 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105594317 | CMS |
| Axsome Therapeutics, Inc. | $125.00 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148400981 | CMS |
| REVANCE THERAPEUTICS, INC. | $118.71 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147939151 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.